EX-101 INSTANCE DOCUMENT
EX-10.11 12 b86941exv10w11.htm EX-10.11 exv10w11
Exhibit 10.11
[Form of] Amendment to Stock Options
Granted Under RXi Pharmaceuticals Corporation 2007 Incentive Plan
Granted Under RXi Pharmaceuticals Corporation 2007 Incentive Plan
This Amendment to Stock Options, dated as of April __, 2011, is made between RXi Pharmaceuticals Corporation, a Delaware corporation (the Company) and the undersigned (the Holder).
WHEREAS, the Holder is the holder of options issued pursuant to the Companys 2007 Incentive Plan (the Plan) to purchase shares of the Companys common stock, $0.0001 par value (the Common Stock); and
WHEREAS, the Holder and the Company have agreed to amend all options issued under the Plan to purchase shares of Common Stock held by the Holder as of the date hereof (the Options) in the manner set forth herein;
NOW THEREFORE, for good and valuable consideration, the Company and the Holder hereby agree as follows:
Notwithstanding anything to the contrary set forth in any applicable option agreement, award or certificate relating to the Options, no Option shall be exercisable unless and until the Companys Certificate of Incorporation has been amended to increase the number of authorized shares of Common Stock to a number that is sufficient to permit the exercise or conversion in full of all then outstanding options (including the Options), warrants and other securities of the Company that are convertible into shares of Common Stock, and each Option shall thereafter be exercisable in accordance with the terms of each such Option.
Except as modified hereby, each Option shall continue in accordance with its terms.
This Amendment to Stock Options may be executed in counterparts, which together shall constitute a single instrument.
[Remainder of page intentionally left blank]
This Amendment to Stock Options is executed as of the date first written above.
RXi Pharmaceuticals Corporation: | |||||
By: | |||||
Mark Ahn, Chief Executive Officer | |||||
Holder: | |||||
Name: | |||||
-2-